Healthcare Sector Snapshot- M&A Will Drive SMID Cap Biopharma now in a Rally Mode
M&A Will Drive SMID Cap Biopharma Healthcare Sector is lagging, Technology sector is coming back in latest month as we enter 3rd week in War with Iran. Biotech M&A is expected to continue throughout 2026 with 14 deals over $500M in Q1. The most promising sector for in Healthcare for...
SMID Biotech Stocks Update to our Trading Model with BULL Market Intact…Update-2
Update-2 4/12/26...Will try to focus on Diagnosiics and Tools this week as Healthcare looked weak.. Hope for some clarity from Abbott (ABT) down 19.95% YTD, on Thursday. Look at Fidelity FSMEX down 27.3% YTD down 22% 1 yr. TMO a favorite, for many years down 14.38% YTD, up 16% one year. BUT I...
Healthcare Sector Watch after a Bad Week, but Biotech is still Tradeable…Update-4..biotech rally!
Update-4 ..4/2/26..uh oh back onto tariff talk again ! NOT good for the market. Tariffs aren't good for business in general. BUT with our WAR in Iran ,and AI they create more chaos. Update-3 4/1/26...Another Green Day for biotech. If you are not in yet a good trade is to buy the IBB at $170,...
Healthcare Sector Review : Q1 2026 Cutbacks in Government Spending are Taking its Toll…Update-4
Update-4 The market continued in its sell-off to the Fifth Week as the WAR in Iran pervades all thinking.If crude is up then stocks will be down. The latest timeline for the War with Iran for any sort of clarity of outcome is around six weeks.In the meantime that period can generate a lot of...
Follow Sector Rotation This Week in Midst of War with Iran…Update-5…MedTech
What is your portfolio allocation by sector?